Samuel M Brown1,2,3, Sarah J Beesley1,2,3, Chris Stubben4, Emily L Wilson1,2, Angela P Presson5, Colin Grissom2,3, Colin Maguire6,7,8, Matthew T Rondina7,8,9, Ramona O Hopkins1,2,10. 1. Center for Humanizing Critical Care, Intermountain Healthcare, Murray, UT, USA. 2. Department of Medicine, Pulmonary and Critical Care Division, 98078Intermountain Medical Center, Murray, UT, USA. 3. Department of Medicine, Pulmonary and Critical Care Division, 7060University of Utah School of Medicine, Salt Lake City, UT, USA. 4. Bioinformatics Shared Resource, 20270Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. 5. Division of Epidemiology, Study Design and Biostatistics Center, 7060University of Utah School of Medicine, Salt Lake City, UT, USA. 6. Center for Translational and Clinical Sciences, 7060University of Utah, Salt Lake City, UT, USA. 7. University of Utah Molecular Medicine Program, 7060University of Utah, Salt Lake City, UT USA. 8. Departments of Internal Medicine and Pathology, 7060University of Utah, Salt Lake City, UT USA. 9. Department of Internal Medicine and the GRECC, George E. Wahlen VAMC, Salt Lake City, UT, USA. 10. Department of Psychology and Neuroscience Center, Brigham Young University, Provo, UT, USA.
Abstract
BACKGROUND: Cognitive impairment after sepsis is an important clinical problem. Determinants of postseptic cognitive impairment are not well understood. We thus undertook a systems biology approach to exploring a possible role for apolipoprotein E (APOE) in postseptic cognitive impairment. DESIGN: Prospective, observational cohort. SETTING: Intermountain Medical Center, a tertiary referral center in Utah. PATIENTS/PARTICIPANTS: Patients with sepsis admitted to study intensive care units. INTERVENTIONS: None. METHODS: We obtained peripheral blood for deep sequencing of RNA and followed up survivors at 6 months with a battery of cognitive instruments. We defined cognitive impairment based on the 6-month Hayling test of executive function. In our primary analysis, we employed weighted network analysis. Secondarily, we compared variation in gene expression between patients with normal versus impaired cognition. MEASUREMENTS AND MAIN RESULTS: We enrolled 40 patients, of whom 34 were follow-up eligible and 31 (91%) completed follow-up; 1 patient's RNA sample was degraded-the final analytic cohort was 30 patients. Mean Hayling test score was 5.8 (standard deviation 1.1), which represented 20% with impaired executive function. The network module containing APOE was dominated by low-expression genes, with no association on primary analysis (P = .8). Secondary analyses suggested several potential lines of future investigation, including oxidative stress. CONCLUSIONS: In this prospective pilot cohort, executive dysfunction affected 1 in 5 survivors of sepsis. The APOE gene was sparsely transcribed in peripheral leukocytes and not associated with cognitive impairment. Future lines of research are suggested.
BACKGROUND: Cognitive impairment after sepsis is an important clinical problem. Determinants of postseptic cognitive impairment are not well understood. We thus undertook a systems biology approach to exploring a possible role for apolipoprotein E (APOE) in postseptic cognitive impairment. DESIGN: Prospective, observational cohort. SETTING: Intermountain Medical Center, a tertiary referral center in Utah. PATIENTS/PARTICIPANTS: Patients with sepsis admitted to study intensive care units. INTERVENTIONS: None. METHODS: We obtained peripheral blood for deep sequencing of RNA and followed up survivors at 6 months with a battery of cognitive instruments. We defined cognitive impairment based on the 6-month Hayling test of executive function. In our primary analysis, we employed weighted network analysis. Secondarily, we compared variation in gene expression between patients with normal versus impaired cognition. MEASUREMENTS AND MAIN RESULTS: We enrolled 40 patients, of whom 34 were follow-up eligible and 31 (91%) completed follow-up; 1 patient's RNA sample was degraded-the final analytic cohort was 30 patients. Mean Hayling test score was 5.8 (standard deviation 1.1), which represented 20% with impaired executive function. The network module containing APOE was dominated by low-expression genes, with no association on primary analysis (P = .8). Secondary analyses suggested several potential lines of future investigation, including oxidative stress. CONCLUSIONS: In this prospective pilot cohort, executive dysfunction affected 1 in 5 survivors of sepsis. The APOE gene was sparsely transcribed in peripheral leukocytes and not associated with cognitive impairment. Future lines of research are suggested.
Authors: G Friedman; P Froom; L Sazbon; I Grinblatt; M Shochina; J Tsenter; S Babaey; B Yehuda; Z Groswasser Journal: Neurology Date: 1999-01-15 Impact factor: 9.910
Authors: Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras Journal: Bioinformatics Date: 2012-10-25 Impact factor: 6.937
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: Fernando A Bozza; Philippe Garteiser; Marcus F Oliveira; Sabrina Doblas; Rebecca Cranford; Debra Saunders; Inna Jones; Rheal A Towner; Hugo C Castro-Faria-Neto Journal: J Cereb Blood Flow Metab Date: 2009-10-21 Impact factor: 6.200
Authors: Dahyun Yi; Dong Y Lee; Bo K Sohn; Young M Choe; Eun H Seo; Min S Byun; Jong I Woo Journal: Am J Geriatr Psychiatry Date: 2014-01-04 Impact factor: 4.105
Authors: Russell R Miller; Li Dong; Nancy C Nelson; Samuel M Brown; Kathryn G Kuttler; Daniel R Probst; Todd L Allen; Terry P Clemmer Journal: Am J Respir Crit Care Med Date: 2013-07-01 Impact factor: 21.405